Rabih Hage1, Sheila R Eshraghi2, Nelson M Oyesiku2, Adriana G Ioachimescu3, Nancy J Newman4, Valérie Biousse5, Beau B Bruce6. 1. Department of Ophthalmology, Emory University, Atlanta, Georgia, USA. 2. Department of Neurological Surgery, Emory University, Atlanta, Georgia, USA. 3. Department of Neurological Surgery, Emory University, Atlanta, Georgia, USA; Department of Medicine, Emory University, Atlanta, Georgia, USA. 4. Department of Ophthalmology, Emory University, Atlanta, Georgia, USA; Department of Neurological Surgery, Emory University, Atlanta, Georgia, USA; Department of Neurology, Emory University, Atlanta, Georgia, USA. 5. Department of Ophthalmology, Emory University, Atlanta, Georgia, USA; Department of Neurology, Emory University, Atlanta, Georgia, USA. 6. Department of Ophthalmology, Emory University, Atlanta, Georgia, USA; Department of Neurology, Emory University, Atlanta, Georgia, USA; Department of Epidemiology, Emory University, Atlanta, Georgia, USA. Electronic address: bbbruce@emory.edu.
Abstract
BACKGROUND: Pituitary apoplexy (PA) often presents with acute headache and neuro-ophthalmic manifestations, including ocular motility dysfunction (OMD) from cranial nerve palsies (CNPs). Our goal was to describe the epidemiology and outcomes of OMD in a large, single-center series of patients with PA. METHODS: We conducted a retrospective chart review of all patients with PA seen in our pituitary center between January 1995 and December 2012. Presenting neuro-ophthalmic, endocrine, and radiologic data, as well as neuro-ophthalmology follow-up data, were collected. RESULTS: We identified 235 patients with PA, 59 of whom (25%) had OMD. Twenty-seven of those 59 patients underwent neuro-ophthalmic evaluation. Preoperatively, 23 of these 27 patients had unilateral OMD, 18 (78%) with a single CNP and 5 (22%) with multiple CNPs. Bilateral OMD was present in 4 of the 27 patients. Postoperatively, 24 of the 27 patients with OMD had follow-up (median duration, 7 months; interquartile range [IQR], 3-17 months). At the last postoperative follow-up, 7 of these 24 patients (29%) had OMD (5 unilateral, 2 bilateral). OMD resolved in 3 of the 24 patients (12%) within 1 month, in 13 of 21 patients (62%) within 6 months (3 lost to follow-up), and in 17 of 19 patients (89%) within 1 year (2 lost to follow-up). Surgery was performed at ≤14 days after presentation in 16 of 18 (89%) resolved cases and in 4 of 6 (67%) unresolved cases. Patients with OMD were more likely than those without OMD to have larger tumors (2.6 vs. 2.0 cm; P < 0.001), panhypopituitarism (31% vs. 14%; P = 0.005), and necrosis (58% vs. 37%; P = 0.03). CONCLUSIONS: OMD from CNPs is common in PA, occurring in one-quarter of patients, and is frequently associated with certain radiologic, endocrinologic, and pathological features. The prognosis is excellent, with 90% of cases of OMD resolving by 1 year after early pituitary surgery.
BACKGROUND: Pituitary apoplexy (PA) often presents with acute headache and neuro-ophthalmic manifestations, including ocular motility dysfunction (OMD) from cranial nerve palsies (CNPs). Our goal was to describe the epidemiology and outcomes of OMD in a large, single-center series of patients with PA. METHODS: We conducted a retrospective chart review of all patients with PA seen in our pituitary center between January 1995 and December 2012. Presenting neuro-ophthalmic, endocrine, and radiologic data, as well as neuro-ophthalmology follow-up data, were collected. RESULTS: We identified 235 patients with PA, 59 of whom (25%) had OMD. Twenty-seven of those 59 patients underwent neuro-ophthalmic evaluation. Preoperatively, 23 of these 27 patients had unilateral OMD, 18 (78%) with a single CNP and 5 (22%) with multiple CNPs. Bilateral OMD was present in 4 of the 27 patients. Postoperatively, 24 of the 27 patients with OMD had follow-up (median duration, 7 months; interquartile range [IQR], 3-17 months). At the last postoperative follow-up, 7 of these 24 patients (29%) had OMD (5 unilateral, 2 bilateral). OMD resolved in 3 of the 24 patients (12%) within 1 month, in 13 of 21 patients (62%) within 6 months (3 lost to follow-up), and in 17 of 19 patients (89%) within 1 year (2 lost to follow-up). Surgery was performed at ≤14 days after presentation in 16 of 18 (89%) resolved cases and in 4 of 6 (67%) unresolved cases. Patients with OMD were more likely than those without OMD to have larger tumors (2.6 vs. 2.0 cm; P < 0.001), panhypopituitarism (31% vs. 14%; P = 0.005), and necrosis (58% vs. 37%; P = 0.03). CONCLUSIONS:OMD from CNPs is common in PA, occurring in one-quarter of patients, and is frequently associated with certain radiologic, endocrinologic, and pathological features. The prognosis is excellent, with 90% of cases of OMD resolving by 1 year after early pituitary surgery.
Authors: Patrick L Semple; Jacques C De Villiers; Robert M Bowen; M Beatriz S Lopes; Edward R Laws Journal: J Neurosurg Date: 2006-06 Impact factor: 5.115
Authors: D C Bills; F B Meyer; E R Laws; D H Davis; M J Ebersold; B W Scheithauer; D M Ilstrup; C F Abboud Journal: Neurosurgery Date: 1993-10 Impact factor: 4.654
Authors: Scott C Seaman; Mark C Dougherty; Mario Zanaty; Leslie A Bruch; Scott M Graham; Jeremy D W Greenlee Journal: J Neurol Surg B Skull Base Date: 2020-06-19
Authors: Mohammed Alahmari; Fahad Alkherayf; Andrea Lasso; Fatmahalzahra Banaz; Sepideh Mohajeri; Pourya Masoudian; Andre Lamothe; Charles Agbi; Lisa Caulley; Mohammad Alshardan; Shaun Kilty Journal: J Neurol Surg B Skull Base Date: 2021-01-21
Authors: Alan Siu; Sanjeet Rangarajan; Michael Karsy; Christopher J Farrell; Gurston Nyquist; Marc Rosen; James J Evans Journal: J Neurol Surg B Skull Base Date: 2021-09-10
Authors: Kevin A Cross; Rupen Desai; Ananth Vellimana; Yupeng Liu; Keith Rich; Gregory Zipfel; Ralph Dacey; Michael Chicoine; Cristine Klatt-Cromwell; Jonathan McJunkin; Patrik Pipkorn; John S Schneider; Julie Silverstein; Albert H Kim Journal: Curr Oncol Date: 2022-07-12 Impact factor: 3.109